Rare diseases
Investigational molecules
Locations
359 conditions with trials, the busiest first
849 trials across Europe, recruiting first
Study on Abrocitinib for Patients with Moderate to Severe Chronic Hand Eczema Unresponsive to Corticosteroids
PolandStudy of LN-144 and LN-145 (Tumor Infiltrating Lymphocytes) in patients with solid tumors, including melanoma, head and neck cancer, and non-small cell lung cancer
GermanyStudy on the Effectiveness and Safety of Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis Using Topical Corticosteroids
BulgariaStudy of Enpatoran in Adults with Systemic Lupus Erythematosus (SLE) and Cutaneous Lupus Erythematosus (CLE)
BulgariaLong-Term Study of Ritlecitinib Tosilate for Adults and Adolescents with Alopecia Areata
CzechiaStudy on the Effectiveness and Safety of Naporafenib Combinations in Patients with Previously Treated Unresectable or Metastatic Melanoma
BelgiumStudy on 5-Fluorouracil and Calcipotriol for Treating Actinic Keratosis in Patients
The NetherlandsStudy on Pritelivir for Treating Acyclovir-Resistant Herpes Simplex Virus in Immunocompromised Patients
BelgiumStudy on the Effects of EVX-01 and Pembrolizumab in Adults with Advanced Melanoma
ItalyStudy of Eltrekibart for Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyStudy on Ianalumab for Patients with Systemic Lupus Erythematosus
FranceStudy Comparing Ipilimumab and Nivolumab with Standard Nivolumab for Patients with Stage III Melanoma
FranceThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
